Bipolar disorder W Randomized controlled trial W Lithium W Carbamazepine W Treatment outcome W Suicide, attempted In a randomized clinical trial with an observation period of 2.5 years, the differential efficacy of lithium versus car-bamazepine was compared in 171 bipolar patients (DSM-IV). In order to investigate the efficacy of the two drugs in clearly defined subsamples, a series of sub-group analyses was carried out. First, patients with a bipolar I disorder (n = 114) were analyzed separately. In these patients, lithium was superior to carbamazepine. In contrast, carbamazepine was at least equally as effica-cious as lithium in the subsample of patients with bipolar II disorder or bipolar disorder not otherwise specifie
Item does not contain fulltextBackground: Alternatives to lithium for prophylactic treatment of pati...
INTRODUCTION: Since extended-release formulations of CBZ have been developed to decrease daily fluct...
Background: Lithium is the established standard in the long-term treatment of bipolar disorder, but ...
In a randomized clinical trial with an observation period of 2.5 years, the differential efficacy of...
In a randomized clinical trial with an observation period of 2.5 years, the differential efficacy of...
In a randomized clinical trial with an observation period of 2.5 years, the differential efficacy of...
In a randomized clinical trial with an observation period of 2.5 years, the differential efficacy of...
In a randomized clinical trial with an observation period of 2.5 years, the differential efficacy of...
Background: Alternatives to lithium for prophylactic treatment of patients with bipolar affective di...
Background: Alternatives to lithium for prophylactic treatment of patients with bipolar affective di...
Background: Alternatives to lithium for prophylactic treatment of patients with bipolar affective di...
Background: Alternatives to lithium for prophylactic treatment of patients with bipolar affective di...
Background: Alternatives to lithium for prophylactic treatment of patients with bipolar affective di...
Background: Alternatives to lithium for prophylactic treatment of patients with bipolar affective di...
Objectives To review data from randomized controlled trials (RCTs) assessing the comparative efficac...
Item does not contain fulltextBackground: Alternatives to lithium for prophylactic treatment of pati...
INTRODUCTION: Since extended-release formulations of CBZ have been developed to decrease daily fluct...
Background: Lithium is the established standard in the long-term treatment of bipolar disorder, but ...
In a randomized clinical trial with an observation period of 2.5 years, the differential efficacy of...
In a randomized clinical trial with an observation period of 2.5 years, the differential efficacy of...
In a randomized clinical trial with an observation period of 2.5 years, the differential efficacy of...
In a randomized clinical trial with an observation period of 2.5 years, the differential efficacy of...
In a randomized clinical trial with an observation period of 2.5 years, the differential efficacy of...
Background: Alternatives to lithium for prophylactic treatment of patients with bipolar affective di...
Background: Alternatives to lithium for prophylactic treatment of patients with bipolar affective di...
Background: Alternatives to lithium for prophylactic treatment of patients with bipolar affective di...
Background: Alternatives to lithium for prophylactic treatment of patients with bipolar affective di...
Background: Alternatives to lithium for prophylactic treatment of patients with bipolar affective di...
Background: Alternatives to lithium for prophylactic treatment of patients with bipolar affective di...
Objectives To review data from randomized controlled trials (RCTs) assessing the comparative efficac...
Item does not contain fulltextBackground: Alternatives to lithium for prophylactic treatment of pati...
INTRODUCTION: Since extended-release formulations of CBZ have been developed to decrease daily fluct...
Background: Lithium is the established standard in the long-term treatment of bipolar disorder, but ...